肝癌精准诊疗新进展

利益冲突声明：所有作者均声明不存在利益冲突。

作者贡献声明：吴彤负责文章撰写; 陈磊负责指导写作，修改论文及最终定稿。

详细信息

New advances in the precision diagnosis and treatment of liver cancer

National Center for Liver Cancer/Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai 200433, China

摘要: 肝癌是严重威胁人类健康的全球性挑战，早发现、早诊断、早治疗是有效改善肝癌患者生存质量、延长生存时间的关键。肝癌发生机制复杂、病因多种多样、个体差异显著，早期诊断和有效治疗始终是难题。在精准医学理念的指导下，以创新的思想，整合应用现代技术与传统方法，通过跨多学科交叉融合，有望破译疾病发生奥秘，不断实现肝癌诊治新突破。
- 肝肿瘤 /
- 诊断 /
- 治疗学
Abstract: Liver cancer is a global challenge that greatly threatens human health, and early identification, early diagnosis, and early treatment are the key to effectively improving quality of life and prolonging survival time for liver cancer patients. Liver cancer has complex pathogeneses, diverse etiologies, and significant heterogeneity between individuals, and early diagnosis and effective treatment have always been difficult issues. Under the guidance of the concept of precision medicine, innovative thoughts combining modern techniques with traditional methods are expected to solve the mystery of disease onset through multidisciplinary integration, thereby achieving new breakthroughs in the diagnosis and treatment of liver cancer.
- Liver Neoplasms /
- Diagnosis /
- Therapeutics

[1]	VILLANUEVA A. Hepatocellular carcinoma[J]. N Engl J Med, 2019, 380(15): 1450-1462. DOI: 10.1056/NEJMra1713263.
[2]	LLOVET JM, KELLEY RK, VILLANUEVA A, et al. Hepatocellular carcinoma[J]. Nat Rev Dis Primers, 2021, 7(1): 6. DOI: 10.1038/s41572-020-00240-3.
[3]	European Association for the Study of the Liver. EASL clinical practice guidelines: Management of hepatocellular carcinoma[J]. J Hepatol, 2018, 69(1): 182-236. DOI: 10.1016/j.jhep.2018.03.019.
[4]	MARRERO JA, KULIK LM, SIRLIN CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases[J]. Hepatology, 2018, 68(2): 723-750. DOI: 10.1002/hep.29913.
[5]	RODRIGUEZ H, ZENKLUSEN JC, STAUDT LM, et al. The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment[J]. Cell, 2021, 184(7): 1661-1670. DOI: 10.1016/j.cell.2021.02.055.
[6]	FONTHAM E, WOLF A, CHURCH TR, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society[J]. CA Cancer J Clin, 2020, 70(5): 321-346. DOI: 10.3322/caac.21628.
[7]	MCCLUNG NM, LEWIS RM, GARGANO JW, et al. Declines in vaccine-type human papillomavirus prevalence in Females Across Racial/Ethnic Groups: Data from a national survey[J]. J Adolesc Health, 2019, 65(6): 715-722. DOI: 10.1016/j.jadohealth.2019.07.003.